Download This PaperThe Cloak of Social Responsibility: Pharmaceutical Corporate Charity
14 Pages Posted: 30 Nov 2016 Last revised: 11 Jan 2024
Date Written: November 28, 2016
Abstract
This report discusses data suggesting that ulterior profit motives may be at the heart of the recent increase in pharmaceutical philanthropy carried out through patient assistance programs (PAPs). The author argues that further research is necessary to explore the cost burden PAPs impose on public payers.
Keywords: Corporate Charity, Pharmaceutical, Patient Assistance Programs, PAPs
JEL Classification: G30, H25
Suggested Citation: Suggested Citation
Frerick, Austin, The Cloak of Social Responsibility: Pharmaceutical Corporate Charity (November 28, 2016). Tax Notes, Vol. 153, Number 9, P. 1151, 2016, Available at SSRN: https://ssrn.com/abstract=2874391 or http://dx.doi.org/10.2139/ssrn.2874391
Do you have a job opening that you would like to promote on SSRN?
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.